The choice of implant design is one of the fundamental decisions in every implantological treatment. Prof. Dr. Dr. Eik Schiegnitz, who headed the Section for Implantology and Augmentation Surgery at the University Medical Centre Mainz, set out in detail on the podcast Queens & Sons of Dentistry why the question "Tissue Level or Bone Level?" has to be answered in a more differentiated way than some trends suggest. His central statement: in medicine, a treatment concept can never be viewed in black and white — in the end, many roads lead to Rome.
Two implant designs, two concepts
Schiegnitz explains the difference as follows: tissue-level implants have a machined collar, that is to say a smooth implant surface without osseointegration; only beneath it does the rough surface begin, which heals into the bone. Bone-level implants, by contrast, have a completely rough surface and are fully osseointegrated.
Historically, implantology began with tissue-level implants. The first implants were tissue-level implants and were successful over a long period. It then became apparent, however, that in specific indications — in the anterior region, for instance — the smooth titanium neck can become visible and cause aesthetic compromises. From this a clear trend towards bone-level implants developed, which can be concealed entirely, while the further design is regulated by way of the abutment.
That trend, however, overshot the mark considerably, according to Schiegnitz: suddenly the claim was that only bone-level implants were still needed, and some speakers even declared tissue-level implants to be contraindicated. The implantologist expressly contradicts this view.
The argument of the microgap
The biological core of his argument is the microgap between the abutment, or implant crown, and the implant. In Schiegnitz's words, this gap is never sealed. With every bite and every word spoken, micromovements arise through which secretion and probably also bacteria are pressed into the immediate surroundings millions of times a day.
In the case of the tissue-level implant, this transition from the crown to the implant lies further away from the crestal bone: the machined collar is as a rule positioned in the soft tissue, so that a certain safety distance to the bone is maintained. The permanent exchange of bacteria at this gap therefore takes place at a greater distance from the bone — in Schiegnitz's assessment the probable explanation for less bone loss and lower peri-implantitis rates.
The Derks study: evidence from real-world care
On the state of the research, Schiegnitz first classifies the methodology: randomised controlled trials — test group, control group, frequently only around 20 patients — are usually regarded as the highest level of scientific evidence. Such studies nevertheless carry a high risk of distortion, a so-called bias: those included are mostly young, completely healthy people, above all men who have lost a tooth through trauma — that is to say precisely not the typical patient in practice.
The Derks study, which he describes as one of the most frequently cited works in implantology, took a different route: as an epidemiological study it brought together all implant restorations placed in Sweden in 2003 — more than 10,000 implants — and examined ten years later which implants had been successful. It includes all practitioners, from the specialist in the clinic to the general dentist in practice, a wide variety of implant systems and a wide variety of patients. For Schiegnitz this reflects reality considerably better, even if, strictly considered, the methodological quality does not match that of a randomised trial.
The result: differentiated by manufacturer, the Straumann system showed markedly higher implant survival rates than other systems. Schiegnitz expressly warns, however, against the premature conclusion that one manufacturer is better than another. What is decisive is which implants of that system were actually used in the Nordic countries in 2003 — namely practically only tissue-level implants, while the remaining manufacturers supplied bone-level implants. The only reasonable statement is therefore: tissue-level implants are probably superior to bone-level implants in terms of long-term implant survival. A follow-up study on the risk of peri-implantitis showed the same picture — markedly lower peri-implantitis rates in long-term follow-up.
Indications in everyday practice
For daily work, Schiegnitz draws a clear conclusion: he continues to regard tissue-level implants as absolutely indicated and, by his own account, places them daily — even more frequently than bone-level implants, above all in the posterior region and in the edentulous jaw, where aesthetic aspects recede into the background. In the aesthetic zone, by contrast, bone-level implants remain the means of choice for him.
Added to this are prosthetic advantages: tissue-level implants are in principle easier for the prosthodontist to take an impression of, because the transition does not lie so deep — which at the same time is less unpleasant for the patient.
Implant selection may sound trivial — "I simply take a titanium screw and turn it in" — yet for anyone striving for absolute excellence, correct implant insertion begins with the choice of the implant, Schiegnitz emphasises. That decision has a direct influence on the later success of the implant.